218 related articles for article (PubMed ID: 16375890)
21. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol.
McMillan DE; Leander JD; Dudley KH
J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
[TBL] [Abstract][Full Text] [Related]
23. Perioperative nimodipine and postoperative analgesia.
Casey G; Nortcliffe SA; Sharpe P; Buggy DJ
Anesth Analg; 2006 Feb; 102(2):504-8. PubMed ID: 16428551
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
Price DD; von der Gruen A; Miller J; Rafii A; Price C
Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
[TBL] [Abstract][Full Text] [Related]
25. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption.
Galinski M; Dolveck F; Combes X; Limoges V; Smaïl N; Pommier V; Templier F; Catineau J; Lapostolle F; Adnet F
Am J Emerg Med; 2007 May; 25(4):385-90. PubMed ID: 17499654
[TBL] [Abstract][Full Text] [Related]
26. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and impact of intravenous morphine before surgical consultation in children with right lower quadrant pain suggestive of appendicitis: a randomized controlled trial.
Bailey B; Bergeron S; Gravel J; Bussières JF; Bensoussan A
Ann Emerg Med; 2007 Oct; 50(4):371-8. PubMed ID: 17597256
[TBL] [Abstract][Full Text] [Related]
28. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.
Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB
Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
30. Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study.
Grach M; Massalha W; Pud D; Adler R; Eisenberg E
Br J Clin Pharmacol; 2004 Sep; 58(3):235-42. PubMed ID: 15327582
[TBL] [Abstract][Full Text] [Related]
31. The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model.
Christensen KS; Cohen AE; Mermelstein FH; Hamilton DA; McNicol E; Babul N; Carr DB
Anesth Analg; 2008 Dec; 107(6):2018-24. PubMed ID: 19020153
[TBL] [Abstract][Full Text] [Related]
32. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
33. Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.
Walter C; Oertel BG; Felden L; Kell CA; Nöth U; Vermehren J; Kaiser J; Deichmann R; Lötsch J
Neuropsychopharmacology; 2016 May; 41(6):1659-69. PubMed ID: 26514581
[TBL] [Abstract][Full Text] [Related]
34. Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication.
Zimmer BD; Bickel P; Dittrich A
Arzneimittelforschung; 1976; 26(8):1614-6. PubMed ID: 795438
[TBL] [Abstract][Full Text] [Related]
35. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.
Schindler EAD; Schnakenberg Martin AM; Sewell RA; Ranganathan M; DeForest A; Pittman BP; Perrino A; D'Souza DC
Psychopharmacology (Berl); 2020 Oct; 237(10):3097-3107. PubMed ID: 32632491
[TBL] [Abstract][Full Text] [Related]
36. [Intra-articular analgesia after anterior cruciate ligament reconstruction].
Musil D; Sadovský P; Stehlík J
Acta Chir Orthop Traumatol Cech; 2007 Jun; 74(3):182-8. PubMed ID: 17623606
[TBL] [Abstract][Full Text] [Related]
37. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
38. Are oral cannabinoids safe and effective in refractory neuropathic pain?
Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
[TBL] [Abstract][Full Text] [Related]
39. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
[TBL] [Abstract][Full Text] [Related]
40. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
